|
1
|
Clements CJ, Baoping Y, Crouch A, Hipgrave
D, Mansoor O, Nelson CB, Treleaven S, van Konkelenberg R and
Wiersma S: Progress in the control of hepatitis B infection in the
Western Pacific Region. Vaccine. 24:1975–1982. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liaw YF: Antiviral therapy of chronic
hepatitis B: Opportunities and challenges in Asia. J Hepatol.
51:403–410. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ott JJ, Stevens GA, Groeger J and Wiersma
ST: Global epidemiology of hepatitis B virus infection: New
estimates of age-specific HBsAg seroprevalence and endemicity.
Vaccine. 30:2212–2219. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liaw YF, Kao JH, Piratvisuth T, Chan HL,
Chien RN, Liu CJ, Gane E, Locarnini S, Lim SG, Han KH, et al:
Asian-Pacific consensus statement on the management of chronic
hepatitis B: A 2012 update. Hepatol Int. 6:531–561. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sarin SK, Kumar M, Lau GK, Abbas Z, Chan
HL, Chen CJ, Chen DS, Chen HL, Chen PJ, Chien RN, et al:
Asian-Pacific clinical practice guidelines on the management of
hepatitis B: A 2015 update. Hepatol Int. 10:1–98. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rukunuzzaman M and Karim MB: Chronic
hepatitis B in children - a review. Mymensingh Med J. 24:649–656.
2015.PubMed/NCBI
|
|
7
|
Bravo AA, Sheth SG and Chopra S: Liver
biopsy. N Engl J Med. 344:495–500. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peng J, Cai S, Yu T, Chen Y, Zhu Y and Sun
J: Aspartate aminotransferase to platelet ratio index-a reliable
predictor of therapeutic efficacy and improvement of Ishak score in
chronic hepatitis B patients treated with nucleoside analogues.
Scand J Clin Lab Invest. 76:133–142. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zeng J, Cai S, Liu J, Xue X, Wu X and
Zheng C: Dynamic changes in liver stiffness measured by transient
elastography predict clinical outcomes among patients with chronic
hepatitis B. J Ultrasound Med. 36:261–268. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cai S, Cao J, Yu T, Xia M and Peng J:
Effectiveness of entecavir or telbivudine therapy in patients with
chronic hepatitis B virus infection pre-treated with interferon
compared with de novo therapy with entecavir and telbivudine.
Medicine (Baltimore). 96:e70212017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
European Association for the Study of
Liver: EASL clinical practical guidelines: Management of alcoholic
liver disease. J Hepatol. 57:399–420. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cai SH, Lv FF, Zhang YH, Jiang YG and Peng
J: Dynamic comparison between Daan real-time PCR and Cobas TaqMan
for quantification of HBV DNA levels in patients with CHB. BMC
Infect Dis. 14:852014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Castera L: Transient elastography and
other noninvasive tests to assess hepatic fibrosis in patients with
viral hepatitis. J Viral Hepat. 16:300–314. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Poynard T and Bedossa P: Age and platelet
count: A simple index for predicting the presence of histological
lesions in patients with antibodies to hepatitis C virus. METAVIR
and CLINIVIR Cooperative Study Groups. J Viral Hepat. 4:199–208.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sandrin L, Fourquet B, Hasquenoph JM, Yon
S, Fournier C, Mal F, Christidis C, Ziol M, Poulet B, Kazemi F, et
al: Transient elastography: A new noninvasive method for assessment
of hepatic fibrosis. Ultrasound Med Biol. 29:1705–1713. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cai S, Yu T, Jiang Y, Zhang Y, Lv F and
Peng J: Comparison of entecavir monotherapy and de novo lamivudine
and adefovir combination therapy in HBeAg-positive chronic
hepatitis B with high viral load: 48-week result. Clin Exp Med.
16:429–436. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sharaiha RZ, Kumta NA, Saumoy M, Desai AP,
Sarkisian AM, Benevenuto A, Tyberg A, Kumar R, Igel L, Verna EC, et
al: Endoscopic sleeve gastroplasty significantly reduces body mass
index and metabolic complications in obese patients. Clin
Gastroenterol Hepatol. 15:504–510. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ou H, Cai S, Liu Y, Xia M and Peng J: A
noninvasive diagnostic model to assess nonalcoholic hepatic
steatosis in patients with chronic hepatitis B. Therap Adv
Gastroenterol. 10:207–217. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang L, Chen S and Xu K: IL-17 expression
is correlated with hepatitis B-related liver diseases and fibrosis.
Int J Mol Med. 27:385–392. 2011.PubMed/NCBI
|
|
20
|
Bai Q, An J, Wu X, You H, Ma H, Liu T, Gao
N and Jia J: HBV promotes the proliferation of hepatic stellate
cells via the PDGF-B/PDGFR-β signaling pathway in vitro. Int
J Mol Med. 30:1443–1450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fagone P, Mangano K, Mammana S, Pesce A,
Pesce A, Caltabiano R, Giorlandino A, Portale TR, Cavalli E, et al:
Identification of novel targets for the diagnosis and treatment of
liver fibrosis. Int J Mol Med. 36:747–752. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fagone P, Mangano K, Pesce A, Portale TR,
Puleo S and Nicoletti F: Emerging therapeutic targets for the
treatment of hepatic fibrosis. Drug Discov Today. 21:369–375. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Q, Xu M, Qu Y, Li Z, Zhang Q, Cai X
and Lu L: Analysis of the differential expression of circulating
microRNAs during the progression of hepatic fibrosis in patients
with chronic hepatitis B virus infection. Mol Med Rep.
12:5647–5654. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lambrecht J, Jan Poortmans P, Verhulst S,
Reynaert H, Mannaerts I and van Grunsven LA: Circulating
ECV-associated miRNAs as potential clinical biomarkers in early
stage HBV and HCV induced liver fibrosis. Front Pharmacol.
8:562017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zheng J, Zhou Z, Xu Z, Li G, Dong P, Chen
Z, Lin D, Chen B and Yu F: Serum microRNA-125a-5p, a useful
biomarker in liver diseases, correlates with disease progression.
Mol Med Rep. 12:1584–1590. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yuen MF, Yuan HJ, Wong DK, Yuen JC, Wong
WM, Chan AO, Wong BC, Lai KC and Lai CL: Prognostic determinants
for chronic hepatitis B in Asians: Therapeutic implications. Gut.
54:1610–1615. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kumar M, Sarin SK, Hissar S, Pande C,
Sakhuja P, Sharma BC, Chauhan R and Bose S: Virologic and
histologic features of chronic hepatitis B virus-infected
asymptomatic patients with persistently normal ALT.
Gastroenterology. 134:1376–1384. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Terrault NA, Bzowej NH, Chang KM, Hwang
JP, Jonas MM and Murad MH: American Association for the Study of
Liver Diseases: AASLD guidelines for treatment of chronic hepatitis
B. Hepatology. 63:261–283. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xue X and Cai S: Comment on ‘assessment of
liver stiffness in pediatric fontan patients using transient
elastography’. Can J Gastroenterol Hepatol. 2016:93439602016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tai DI, Lin SM, Sheen IS, Chu CM, Lin DY
and Liaw YF: Long-term outcome of hepatitis B e antigen-negative
hepatitis B surface antigen carriers in relation to changes of
alanine aminotransferase levels over time. Hepatology.
49:1859–1867. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Prati D, Taioli E, Zanella A, Della Torre
E, Butelli S, Del Vecchio E, Vianello L, Zanuso F, Mozzi F, Milani
S, et al: Updated definitions of healthy ranges for serum alanine
aminotransferase levels. Ann Intern Med. 137:1–10. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin CL, Liao LY, Liu CJ, Yu MW, Chen PJ,
Lai MY, Chen DS and Kao JH: Hepatitis B viral factors in
HBeAg-negative carriers with persistently normal serum alanine
aminotransferase levels. Hepatology. 45:1193–1198. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kumar M, Sharma P, Garg H, Kumar R, Bhatia
V and Sarin SK: Transient elastographic evaluation in adult
subjects without overt liver disease: Influence of alanine
aminotransferase levels. J Gastroenterol Hepatol. 26:1318–1325.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yasuda M, Shimizu I, Shiba M and Ito S:
Suppressive effects of estradiol on dimethylnitrosamine-induced
fibrosis of the liver in rats. Hepatology. 29:719–727. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lemoine M, Thursz M, Mallet V and
Shimakawa Y: Diagnostic accuracy of the gamma-glutamyl
transpeptidase to platelet ratio (GPR) using transient elastography
as a reference. Gut. 66:195–196. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li Q, Lu C, Li W, Huang Y and Chen L: The
independent predictors of significant liver histological changes in
chronic hepatitis B virus infection patients with persistently
high-normal or low-normal alanine transaminase levels. Discov Med.
23:19–25. 2017.PubMed/NCBI
|
